Gene therapy—why is UK going full pelt into a minefield?
Find out here, and it's not good news
Why do I keep banging on about gene therapy?
COVID-19 has been manna from heaven for companies developing gene therapy-based products. What lots don't know is they had been languishing in the doldrums for a very long time prior to the SARS-CoV-2 (alleged) outbreak.
Proving they were safe and effective was holding everything up, and still is, if we refer to the Cell and Gene Therapy Catapult UK Clinical Trials Report, which includes the Cell and Gene Therapy Catapult ATMP Clinical Trials Database 2021.
The database is 29 pages of clinical trials in various stages of progress. Start dates range from 2004 to 2021. Trust me, the problems are horrendous, and that’s what has been holding things up.
What are these problems?
I did a post on this in March, and re-post it here.
It recounts one of the first gene therapy products to be approved, Novartis’ Kymriah.
Here you can see the package insert from the FDA website.
This is the warning on there:
“WARNING: CYTOKINE RELEASE SYNDROME and NEUROLOGICAL T…